The Atlantic

Ozempic Can Turn Into No-zempic

The obesity-drug revolution is leaving lots of people behind.
Source: Katie Martin

No medication in the history of modern weight loss has inspired as much awe as the latest class of obesity drugs. Wegovy and Zepbound are so effective that they are often likened to “magic and “miracles.” Indeed, the weekly injections, which belong to a broader class known as GLP-1s, can lead to weight loss of 20 percent or more, fueling hype about a future in which many more millions of Americans take them. Major food companies including Nestlé and Conagra are considering tailoring their products to suit GLP-1 users. Underlying all this excitement is a huge assumption: They work for everyone.

But for a lot of people, they just . Anita, who lives in Arizona, told me she “took it for granted” that she would lose weight on

You’re reading a preview, subscribe to read more.

More from The Atlantic

The Atlantic4 min read
Trump Secures His Get-Out-of-Jail-Free Card
When the Supreme Court agreed to take up the question of whether Donald Trump is shielded from prosecution over his role in January 6, two core questions were at stake. First was the substantive matter of whether the Court would find that presidentia
The Atlantic7 min read
The Awful Ferocity of Midlife Desire
The protagonist of Last Summer, a lawyer named Anne (played by Léa Drucker), lives in the Gallic version of a Nancy Meyers utopia: a resplendent French country home with parquet floors, velvet throw pillows, and the faintest hum of ennui. Anne dresse
The Atlantic3 min read
Donald Trump’s Theory of Everything
At Thursday’s debate, while Joe Biden struggled to put a sentence together, Donald Trump struggled to utter any sentence that wasn’t about illegal immigrants destroying the country. Harsh rhetoric—and policy—on migrants and the border has long been a

Related Books & Audiobooks